Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0086 | 0.9 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |